Retraction: Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases

PLOS One Editors. PLoS One. 2025.

. 2025 Mar 18;20(3):e0321152.

doi: 10.1371/journal.pone.0321152. eCollection 2025.

No abstract available

Retraction of

Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer's and Parkinson's diseases.
Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, Mizuno H, Spencer B, Rockenstein E, Trejo M, Platoshyn O, Yuan JX, Masliah E. Tsigelny IF, et al. PLoS One. 2008 Sep 4;3(9):e3135. doi: 10.1371/journal.pone.0003135. PLoS One. 2008. Retraction in: PLoS One. 2025 Mar 18;20(3):e0321152. doi: 10.1371/journal.pone.0321152. PMID: 18769546 Free PMC article. Retracted.

1. Tsigelny IF, Crews L, Desplats P, Shaked GM, Sharikov Y, Mizuno H, et al.. Mechanisms of hybrid oligomer formation in the pathogenesis of combined Alzheimer’s and Parkinson’s diseases. PLoS ONE. 2008;3(9): e3135. doi: 10.1371/journal.pone.0003135 - DOI - PMC - PubMed
1. Overk CR, Cartier A, Shaked G, Rockenstein E, Ubhi K, Spencer B, et al.. Hippocampal neuronal cells that accumulate α-synuclein fragments are more vulnerable to Aβ oligomer toxicity via mGluR5--implications for dementia with Lewy bodies. Mol Neurodegener. 2014;9: 18. doi: 10.1186/1750-1326-9-18 - DOI - PMC - PubMed